2019 წლის კორონავირუსით გამოწვეული დაავადება (COVID-19)

Просмотреть PDF

Обзор 
Теория 
Диагноз 
Лечение 
Последующее наблюдение 
Источники 

Этот раздел доступен бесплатно

Международные руководства

Великобритания

Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19

Опубликовано:National Institute for Health and Care Excellence

Последняя публикация:2024

COVID-19 rapid guideline: managing COVID-19

Опубликовано:National Institute for Health and Care Excellence

Последняя публикация:2024

Remdesivir and tixagevimab plus cilgavimab for treating COVID-19

Опубликовано:National Institute for Health and Care Excellence

Последняя публикация:2024

COVID-19: the green book, chapter 14a

Опубликовано:UK Health Security Agency

Последняя публикация:2024

Coronavirus (COVID-19): guidance

Опубликовано:UK Health Security Agency

Последняя публикация:2024

Coronavirus (COVID-19) infection in pregnancy

Опубликовано:Royal College of Obstetricians and Gynaecologists

Последняя публикация:2022

Prevention and management of venous thromboembolism in COVID-19

Опубликовано:Scottish Intercollegiate Guidelines Network

Последняя публикация:2021

Европа

ESCMID COVID-19 guidelines

Опубликовано:European Society of Clinical Microbiology and Infectious Diseases

Последняя публикация:2023

Management of hospitalised adults with coronavirus disease-19 (COVID-19)

Опубликовано:European Respiratory Society

Последняя публикация:2021

Recommendations for COVID-19 clinical management

Опубликовано:National Institute for the Infectious Diseases (Italy)

Последняя публикация:2020

Северная Америка

Interim infection prevention and control recommendations for healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic

Опубликовано:Centers for Disease Control and Prevention

Последняя публикация:2024

Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: serologic testing

Опубликовано:Infectious Diseases Society of America

Последняя публикация:2024

Interim clinical considerations for use of COVID-19 vaccines in the United States

Опубликовано:Centers for Disease Control and Prevention

Последняя публикация:2024

Coronavirus disease 2019 (COVID-19) treatment guidelines

Опубликовано:National Institutes of Health

Последняя публикация:2024

Overview of testing for SARS-CoV-2, the virus that causes COVID-19

Опубликовано:Centers for Disease Control and Prevention

Последняя публикация:2024

Healthcare workers: information on COVID-19

Опубликовано:Centers for Disease Control and Prevention

Последняя публикация:2024

Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19

Опубликовано:Infectious Diseases Society of America

Последняя публикация:2023

COVID-19 interim guidance

Опубликовано:American Academy of Pediatrics

Последняя публикация:2023

Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: molecular diagnostic testing

Опубликовано:Infectious Diseases Society of America

Последняя публикация:2023

Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: antigen testing

Опубликовано:Infectious Diseases Society of America

Последняя публикация:2022

COVID-19 testing guidance

Опубликовано:American Academy of Pediatrics

Последняя публикация:2022

Infectious Diseases Society of America guidelines on infection prevention for healthcare personnel caring for patients with suspected or known COVID-19

Опубликовано:Infectious Diseases Society of America

Последняя публикация:2021

Океания

Care for adults with COVID-19: living guidelines

Опубликовано:Australian National COVID-19 Clinical Evidence Taskforce

Последняя публикация:2022

Coronavirus disease 2019 (COVID-19)

Опубликовано:Department of Health Australia

Последняя публикация:2022

Азия

Clinical guidance for management of adult COVID-19 patients

Опубликовано:All India Institute Of Medical Sciences; Indian Council of Medical Research

Последняя публикация:2023

Остальной мир